BIOCON
|
The Current P/B Ratio of BIOCON is 1.75.
| Share Price | ₹360.5 | Oct 07,2026 |
| Market Cap | ₹58,750.7 Cr | |
| Book Value | ₹33,517.5 Cr | Mar2026 - Consolidated Results |
| Price/Book | 1.75x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of BIOCON
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹58,750.7 Cr] as on Oct 07,2026
(/) Book Value [ ₹33,517.5 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 1.75x ]
Thus, for BIOCON , the investors are currently willing to pay '1.75 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BIOCON !
The chart below summarizes the trend in P/B Ratio of BIOCON over the last five years.
Historical PB (Price/Book ) ratio chart of BIOCON
PB Ratio Performance Analysis for BIOCON
- BIOCON 's p/b ratio for fiscal years ending Mar2026 to Mar2022 averaged 2.32x.
- BIOCON 's operated at median p/b ratio of 1.75x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOCON 's p/b ratio peaked in Mar2022 at 4.88x.
- BIOCON 's p/b ratio hit its five-year low in Mar2023 of 1.41x.
How does BIOCON 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| BIOCON | 33,517.50 | 1.75 | 58,750.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.12 | 427,861.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 15.17 | 254,319.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 21.36 | 179,153.0 |
| CIPLA LTD | 34,369.40 | 3.13 | 107,406.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.66 | 100,362.0 |
| MANKIND PHARMA LTD | 16,252.60 | 6.34 | 103,049.0 |
| LUPIN LTD | 22,384.10 | 4.10 | 91,782.7 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.25 | 115,112.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.56 | 96,951.2 |
| LAURUS LABS LTD | 5,275.08 | 21.05 | 111,034.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BIOCON 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 1.75x |
| Max industry PB | 21.36x |
| Median industry PB | 4.25x |
| Average industry PB | 7.95x |
You may also like the below Video Courses